Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F13PD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,918
Award facts
- Contract value 100% obligated
- $10,917.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,917.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Trulicity 0.75 mg/0.5 ml pen in 0.5 ml dosage. The award, issued January 9, 2026, with completion targeted for January 12, 2026, was not set aside and represents a competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling value through December 2026 and serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs. The company's extensive federal contract portfolio demonstrates consistent capability to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains through competitively awarded firm fixed-price arrangements. The underlying IDC with DLA Troop Support Medical represents a comprehensive global pharmaceutical support vehicle enabling the company to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA Troop Support planning future Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DR26F13PD?
SPE2DR26F13PD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F13PD worth?
The government has obligated $10,918 on SPE2DR26F13PD.
Is contract SPE2DR26F13PD an order under another contract?
Yes. SPE2DR26F13PD is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13PD competed?
The extent of competition for SPE2DR26F13PD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award